BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24483936)

  • 21. Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons.
    Matalonga L; Arias Á; Tort F; Ferrer-Cortés X; Garcia-Villoria J; Coll MJ; Gort L; Ribes A
    Neurotherapeutics; 2015 Oct; 12(4):874-86. PubMed ID: 26169295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs).
    Campofelice A; Lentini L; Di Leonardo A; Melfi R; Tutone M; Pace A; Pibiri I
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
    Aslam AA; Higgins C; Sinha IP; Southern KW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD012040. PubMed ID: 28102546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudouridine-mediated stop codon readthrough in
    Adachi H; Yu YT
    RNA; 2020 Sep; 26(9):1247-1256. PubMed ID: 32434780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR.
    Smith E; Dukovski D; Shumate J; Scampavia L; Miller JP; Spicer TP
    SLAS Discov; 2021 Feb; 26(2):205-215. PubMed ID: 33016182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion.
    Sharma J; Du M; Wong E; Mutyam V; Li Y; Chen J; Wangen J; Thrasher K; Fu L; Peng N; Tang L; Liu K; Mathew B; Bostwick RJ; Augelli-Szafran CE; Bihler H; Liang F; Mahiou J; Saltz J; Rab A; Hong J; Sorscher EJ; Mendenhall EM; Coppola CJ; Keeling KM; Green R; Mense M; Suto MJ; Rowe SM; Bedwell DM
    Nat Commun; 2021 Jul; 12(1):4358. PubMed ID: 34272367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restoration of W1282X CFTR activity by enhanced expression.
    Rowe SM; Varga K; Rab A; Bebok Z; Byram K; Li Y; Sorscher EJ; Clancy JP
    Am J Respir Cell Mol Biol; 2007 Sep; 37(3):347-56. PubMed ID: 17541014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Suppression of Nonsense Mutation: An Emerging Target in Multiple Diseases and Thrombotic Disorders.
    Asiful Islam M; Alam F; Kamal MA; Gan SH; Wong KK; Sasongko TH
    Curr Pharm Des; 2017; 23(11):1598-1609. PubMed ID: 27875971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations.
    McHugh DR; Cotton CU; Hodges CA
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
    Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
    BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations.
    Peabody Lever JE; Mutyam V; Hathorne HY; Peng N; Sharma J; Edwards LJ; Rowe SM
    Pediatr Pulmonol; 2020 Jul; 55(7):1838-1842. PubMed ID: 32281737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoglycoside-mediated promotion of translation readthrough occurs through a non-stochastic mechanism that competes with translation termination.
    Chowdhury HM; Siddiqui MA; Kanneganti S; Sharmin N; Chowdhury MW; Nasim MT
    Hum Mol Genet; 2018 Jan; 27(2):373-384. PubMed ID: 29177465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gentamicin inducing readthrough premature stop Codons: A study of alpha-L-iduronidase nonsense variants in COS-7 Cells.
    Ngiwsara L; Sawangareetrakul P; Wattanasirichaigoon D; Tim-Aroon T; Dejkhamron P; Champattanachai V; Ketudat-Cairns JR; Svasti J
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):147-154. PubMed ID: 36332477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells.
    Chiavetta RF; Titoli S; Barra V; Cancemi P; Melfi R; Di Leonardo A
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations.
    Lebeda D; Fierenz A; Werfel L; Rosin-Arbesfeld R; Hofhuis J; Thoms S
    J Mol Med (Berl); 2024 May; 102(5):641-653. PubMed ID: 38430393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translation termination codons in protein synthesis and disease.
    Lombardi S; Testa MF; Pinotti M; Branchini A
    Adv Protein Chem Struct Biol; 2022; 132():1-48. PubMed ID: 36088072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2'-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR.
    Carollo PS; Tutone M; Culletta G; Fiduccia I; Corrao F; Pibiri I; Di Leonardo A; Zizzo MG; Melfi R; Pace A; Almerico AM; Lentini L
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutations.
    Salvatori F; Cantale V; Breveglieri G; Zuccato C; Finotti A; Bianchi N; Borgatti M; Feriotto G; Destro F; Canella A; Breda L; Rivella S; Gambari R
    Biotechnol Appl Biochem; 2009 Jul; 54(1):41-52. PubMed ID: 19216718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons.
    Kuschal C; DiGiovanna JJ; Khan SG; Gatti RA; Kraemer KH
    Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19483-8. PubMed ID: 24218596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients.
    Sarkar C; Zhang Z; Mukherjee AB
    Mol Genet Metab; 2011 Nov; 104(3):338-45. PubMed ID: 21704547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.